EDGAR Filing Documents for 0001193125-13-224425

Form 8-K - Current report:

SEC Accession No. 0001193125-13-224425

Filing Date

2013-05-16

Accepted

2013-05-16 17:09:01

Documents

Period of Report

2013-05-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d540390d8k.htm	8-K	22685
2	EX-99.1	d540390dex991.htm	EX-99.1	15080
3	EX-99.2	d540390dex992.htm	EX-99.2	19538
4	GRAPHIC	g540390g06q11.jpg	GRAPHIC	12492
5	GRAPHIC	g540390img02.jpg	GRAPHIC	11982
	Complete submission text file	0001193125-13-224425.txt		92675

Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125

Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456

SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)